CBDA has been found to be even more effective in treating anxiety, pain, insomnia, nausea, and epilepsy. In fact, the molecular structure of CBDa closely resembles non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen. The most important factor in achieving success with CBD is using the right amount and the widest range of plant compounds, including CBDA, that fits your specific needs. There is also evidence based on animal studies that CBDA is more potent than CBD and CBDA, not only because CBDA is absorbed more effectively, but also because it acts more effectively.
Because of the exciting therapeutic potential of CBDA, researchers have tried to create synthetic versions that can be used for therapeutic applications. In addition, even many of the good quality products have confusing labels that make it difficult to know how much CBD and CBDA are in each serving. Nesa hemp is full of CBDA that can help calm the nervous system and allow people to fall asleep faster. CBDA is similar to CBD in a variety of target areas of the body, however, it has been shown to be more absorbable and more potent in a variety of studies.
According to Ponomariovaite, pure CBDA hemp extract has been shown to be beneficial as an antioxidant and anti-inflammatory agent, resulting in good things when it comes to a healthy heart. Essentially, their studies concluded that lower doses of CBDA were needed to be effective, thus reducing the risk of negative side effects from CBDA. Before buying a CBD product that you plan to use for anxiety, be sure to consult the Certificate of Analysis (COA), a test result from an external laboratory that details the content of CBD and other cannabinoids (such as CBDA) and terpenes, and that it is free of contamination with heavy metals and pesticides. A preclinical study focusing on the downregulation of Cox-2 enzymes found that CBDA could help suppress the spread of a specific type of breast cancer cells.
CBDA has demonstrated enormous potential in treating a variety of conditions including anxiety, nausea and vomiting, epilepsy and cancer. GW Pharma, the pharmaceutical company responsible for Epidiolex, has conducted studies comparing the effects of CBDA versus CBD. When the acid form is decarboxylated, CBDA is transformed into CBD, the active ingredient in many infused products. In a process called decarboxylation, CBDA, THCA and other acidic compounds are converted into their decarboxylated forms, known as the main psychoactive cannabinoids (THC, CBC, CBD, etc.) that can positively affect the body.
